ALZN Stock Analysis: Buy, Sell, or Hold?

ALZN - Alzamend Neuro, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.03
0.00 (0.00%) ▲
5d: -3.74%
30d: +3.0%
90d: -36.81%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Mar 09, 2026 0d

Get Alerted When ALZN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: ALZN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ALZN is currently trading at $1.03, which is considered fair relative to its 30-day fair value range of $0.97 to $1.12.

Technical Outlook: Technically, ALZN is in a strong downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $25.00 (+2327.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.97 - $1.12
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 2327.2% below Wall St target ($25.00)

Trading Range Analysis

30-Day Trading Range $0.97 - $1.12
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $1.00
Resistance Level $1.16
Current Trend Strong Downtrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) -0.40
Wall Street Target $25.00 (+2327.2%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 15, 2026 10:07 AM ET
Data refreshes hourly during market hours. Next update: 11:07 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Milton C Ault III BUY 108388 shares 2026-04-14
Milton C Ault III SELL 1851 shares 2025-12-23
William B Horne SELL 3333 shares 2025-12-19

Unlock Insider Activity

See real-time buying/selling by company executives for ALZN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1036 58 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$73 58 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 55 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$297 59 HOLD
BEAM
Beam Therapeutics Inc
STRONG BUY
17 analysts
$51 58 HOLD

More Analysis for ALZN

ALZN Technical Chart ALZN Price Prediction ALZN Earnings Date ALZN Investment Advisor ALZN Fair Price Analyzer ALZN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals